Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG

MERTLÍKOVÁ-KAISEROVÁ, H., RUMLOVÁ, M., TLOUŠŤOVÁ, E., PROCHÁZKOVÁ, E., HOLÝ, A., VOTRUBA, I. Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG. Biochemical Pharmacology. 2011, 82(2), 131-138. ISSN 0006-2952. E-ISSN 1873-2968. Available: doi: 10.1016/j.bcp.2011.04.002